Business Context and Reporting Period
This Form 8-K filing by BioSig Technologies, Inc. (not Streamex Corp.) reports on a special meeting of stockholders held on December 27, 2023. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
The primary event reported is the approval of a proposal to authorize the issuance of common stock underlying certain warrants. This issuance is necessary to comply with Nasdaq Listing Rule 5635(d) regarding transactions exceeding 20% of outstanding shares. The warrants relate to:
- A Securities Purchase Agreement dated November 8, 2023, with an institutional investor.
- An Engagement Agreement dated October 31, 2023, with H.C. Wainwright & Co., LLC.
Voting Statistics:
| Category | Votes |
|---|---|
| Total Votes Entitled | 81,764,421 (81,110,643 Common + 653,778 Series C Preferred) |
| For | 39,295,753 |
| Against | 1,226,390 |
| Abstain | 1,097,327 |
| Broker Non-Votes | 0 |
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the context of the warrant issuance. The approval of the Issuance Proposal enables the company to proceed with the warrant exercises associated with the November and October 2023 agreements.
Key Facts for Investor Verification
- Verify the definitive proxy statement filed on December 1, 2023, for detailed terms of the warrant agreements.
- Confirm the dilution impact of the warrant exercises on existing shareholders, as the issuance exceeds 20% of pre-issuance outstanding shares.
- Review the specific terms of the Series C Convertible Preferred Stock to understand the voting rights exercised by those holders.
- Check subsequent filings for the actual issuance of shares and the capital raised from the institutional investor and H.C. Wainwright & Co., LLC.